Journal of Dental Research
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Hedgehog Signaling Is Evolutionarily Conserved Cilium-Independent
Downloaded from genesdev.cshlp.org on August 14, 2009 - Published by Cold Spring Harbor Laboratory Press Cilium-independent regulation of Gli protein function by Sufu in Hedgehog signaling is evolutionarily conserved Miao-Hsueh Chen, Christopher W. Wilson, Ya-Jun Li, et al. Genes Dev. 2009 23: 1910-1928 Access the most recent version at doi:10.1101/gad.1794109 Supplemental http://genesdev.cshlp.org/content/suppl/2009/07/23/23.16.1910.DC1.html Material References This article cites 97 articles, 47 of which can be accessed free at: http://genesdev.cshlp.org/content/23/16/1910.full.html#ref-list-1 Email alerting Receive free email alerts when new articles cite this article - sign up in the box at the service top right corner of the article or click here To subscribe to Genes & Development go to: http://genesdev.cshlp.org/subscriptions Copyright © 2009 by Cold Spring Harbor Laboratory Press Downloaded from genesdev.cshlp.org on August 14, 2009 - Published by Cold Spring Harbor Laboratory Press Cilium-independent regulation of Gli protein function by Sufu in Hedgehog signaling is evolutionarily conserved Miao-Hsueh Chen,1,3 Christopher W. Wilson,1,3 Ya-Jun Li,1 Kelvin King Lo Law,2 Chi-Sheng Lu,1 Rhodora Gacayan,1 Xiaoyun Zhang,2 Chi-chung Hui,2 and Pao-Tien Chuang1,4 1Cardiovascular Research Institute, University of California at San Francisco, San Francisco, California 94158, USA; 2Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, and Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5G 1L7, Canada A central question in Hedgehog (Hh) signaling is how evolutionarily conserved components of the pathway might use the primary cilium in mammals but not fly. -
Genetic Mutations Underlying Phenotypic Plasticity in Basosquamous Carcinoma Audris Chiang1,2,7, Caroline Z
See related commentary on pg 2258 ORIGINAL ARTICLE Genetic Mutations Underlying Phenotypic Plasticity in Basosquamous Carcinoma Audris Chiang1,2,7, Caroline Z. Tan1,7, Franc¸ois Kuonen1, Luqman M. Hodgkinson1, Felicia Chiang3, Raymond J. Cho4, Andrew P. South5,JeanY.Tang1, Anne Lynn S. Chang1, Kerri E. Rieger1,6, Anthony E. Oro1 and Kavita Y. Sarin1 Basosquamous carcinoma (BSC) is an aggressive skin neoplasm with the features of both basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). While genetic drivers of BCC and SCC development have been extensively characterized, BSC has not been well studied, and it remains unclear whether these tumors orig- inally derive from BCC or SCC. In addition, it is unknown which molecular pathways mediate the reprog- ramming of tumor keratinocytes toward basaloid or squamatized phenotypes. We sought to characterize the genomic alterations underlying sporadic BSC to elucidate the derivation of these mixed tumors. We identifed frequent Hedgehog (Hh) pathway mutations in BSCs, implicating Hh deregulation as the primary driving event in BSC. Principal component analysis of BCC and SCC driver genes further demonstrate the genetic similarity between BCC and BSC. In addition, 45% of the BSCs harbor recurrent mutations in the SWI/SNF complex gene, ARID1A, and evolutionary analysis revealed that ARID1A mutations occur after PTCH1 but before SCC driver mutations, indicating that ARID1A mutations may bestow plasticity enabling squamatization. Finally, we demonstrate mitogen-activated protein kinase pathway activation and the loss of Hh signaling associated with the squamatization of BSCs. Overall, these results support the genetic derivation of BSCs from BCCs and highlight potential factors involved in modulating tumor reprogramming between basaloid and squamatized phenotypes. -
Recent Advances in Signaling Pathways Comprehension As Carcinogenesis Triggers in Basal Cell Carcinoma
Journal of Clinical Medicine Review Recent Advances in Signaling Pathways Comprehension as Carcinogenesis Triggers in Basal Cell Carcinoma Mircea Tampa 1,2, Simona Roxana Georgescu 1,2,*, Cristina Iulia Mitran 3, Madalina Irina Mitran 3, Clara Matei 1, Cristian Scheau 4 , Carolina Constantin 5,6 and Monica Neagu 5,6,7 1 Department of Dermatology, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania; [email protected] (M.T.); [email protected] (C.M.) 2 Department of Dermatology, “Victor Babes” Clinical Hospital for Infectious Diseases, 030303 Bucharest, Romania 3 Department of Microbiology, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania; [email protected] (C.I.M.); [email protected] (M.I.M.) 4 Department of Physiology, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania; [email protected] 5 Immunology Department, “Victor Babes” National Institute of Pathology, 050096 Bucharest, Romania; [email protected] (C.C.); [email protected] (M.N.) 6 Colentina Clinical Hospital, 020125 Bucharest, Romania 7 Faculty of Biology, University of Bucharest, 76201 Bucharest, Romania * Correspondence: [email protected] Received: 18 July 2020; Accepted: 16 September 2020; Published: 18 September 2020 Abstract: Basal cell carcinoma (BCC) is the most common malignant skin tumor. BCC displays a different behavior compared with other neoplasms, has a slow evolution, and metastasizes very rarely, but sometimes it causes an important local destruction. Chronic ultraviolet exposure along with genetic factors are the most important risk factors involved in BCC development. Mutations in the PTCH1 gene are associated with Gorlin syndrome, an autosomal dominant disorder characterized by the occurrence of multiple BCCs, but are also the most frequent mutations observed in sporadic BCCs. -
Loss of the PTCH1 Tumor Suppressor Defines a New
Banerjee et al. J Transl Med (2019) 17:246 https://doi.org/10.1186/s12967-019-1995-z Journal of Translational Medicine RESEARCH Open Access Loss of the PTCH1 tumor suppressor defnes a new subset of plexiform fbromyxoma Sudeep Banerjee1,2, Christopher L. Corless3, Markku M. Miettinen4, Sangkyu Noh1, Rowan Ustoy1, Jessica L. Davis3, Chih‑Min Tang1, Mayra Yebra1, Adam M. Burgoyne5 and Jason K. Sicklick1* Abstract Background: Plexiform fbromyxoma (PF) is a rare gastric tumor often confused with gastrointestinal stromal tumor. These so‑called “benign” tumors often present with upper GI bleeding and gastric outlet obstruction. It was recently demonstrated that approximately one‑third of PF have activation of the GLI1 oncogene, a transcription factor in the hedgehog (Hh) pathway, via a MALAT1‑GLI1 fusion protein or GLI1 up‑regulation. Despite this discovery, the biology of most PFs remains unknown. Methods: Next generation sequencing (NGS) was performed on formalin‑fxed parafn‑embedded (FFPE) samples of PF specimens collected from three institutions (UCSD, NCI and OHSU). Fresh frozen tissue from one tumor was utilized for in vitro assays, including quantitative RT‑PCR and cell viability assays following drug treatment. Results: Eight patients with PF were identifed and 5 patients’ tumors were analyzed by NGS. An index case had a mono‑allelic PTCH1 deletion of exons 15–24 and a second case, identifed in a validation cohort, also had a PTCH1 gene loss associated with a suspected long‑range chromosome 9 deletion. Building on the role of Hh signaling in PF, PTCH1, a tumor suppressor protein, functions upstream of GLI1. Loss of PTCH1 induces GLI1 activation and down‑ stream gene transcription. -
Multivariate Meta-Analysis of Differential Principal Components Underlying Human Primed and Naive-Like Pluripotent States
bioRxiv preprint doi: https://doi.org/10.1101/2020.10.20.347666; this version posted October 21, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license. October 20, 2020 To: bioRxiv Multivariate Meta-Analysis of Differential Principal Components underlying Human Primed and Naive-like Pluripotent States Kory R. Johnson1*, Barbara S. Mallon2, Yang C. Fann1, and Kevin G. Chen2*, 1Intramural IT and Bioinformatics Program, 2NIH Stem Cell Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA Keywords: human pluripotent stem cells; naive pluripotency, meta-analysis, principal component analysis, t-SNE, consensus clustering *Correspondence to: Dr. Kory R. Johnson ([email protected]) Dr. Kevin G. Chen ([email protected]) 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.10.20.347666; this version posted October 21, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license. ABSTRACT The ground or naive pluripotent state of human pluripotent stem cells (hPSCs), which was initially established in mouse embryonic stem cells (mESCs), is an emerging and tentative concept. To verify this important concept in hPSCs, we performed a multivariate meta-analysis of major hPSC datasets via the combined analytic powers of percentile normalization, principal component analysis (PCA), t-distributed stochastic neighbor embedding (t-SNE), and SC3 consensus clustering. -
Understanding the Application: NGS Panel Testing for Hereditary Cancer Syndromes and Cancer Targeted Therapy
Understanding the Application: NGS Panel Testing for Hereditary Cancer Syndromes and Cancer Targeted Therapy Felicitas L. Lacbawan, MD, FCAP, FACMG Medical Director, Genetics Quest Diagnostics Nichols Institute, San Juan Capistrano, CA USA February 9, 2016 [email protected] http://www.cancer.org/acs/groups/content/@editorial/documents/document/acspc-044552.pdf 2 http://www.nature.com/onc/journal/v23/n38/full/1207714a.html Hereditary Cancers About 5% to 10% of all cancers Inheriting a gene mutation or pathogenic variant does not necessarily mean that a person will develop cancer, but it increases his/her risk Most common hereditary cancers are: Breast cancer Ovarian cancer Colorectal cancer Prostate cancer Understanding if cancer is due to an inherited pathogenic variant/mutation can help clarify future risks of developing cancer and help determine options for cancer screening and prevention, possibly therapy 5 Lifetime Cancer Risks for Common Cancers Cancer Risk (%) Cancer Type http://seer.cancer.gov/ Lifetime Risks: Breast Cancer “Red Flags” for Inherited Susceptibility to Cancer Cancer in 2 or more closely related relatives Multiple generations affected Early age at diagnosis Multiple primary tumors Bilateral or rare cancers Constellation of tumors consistent with a specific cancer syndrome Certain ethnic backgrounds (e.g. Ashkenazi Jewish ancestry) 8 Assessing Patient’s Family History Ovarian, 52 Breast, 42 Breast, 45 9 Cost per Genome Decreasing Dramatically Diagnostic Applications of Sequencing -
Coincident Two Mutations and One Single Nucleotide Polymorphism of the PTCH1 Gene in a Family with Naevoid Basal Cell Carcinoma Syndrome
Letters to the Editor 635 Coincident Two Mutations and One Single Nucleotide Polymorphism of the PTCH1 Gene in a Family with Naevoid Basal Cell Carcinoma Syndrome Shoko Abe1, Kenji Kabashima1*, Jun-ichi Sakabe1, Takatoshi Shimauchi1, Zhang Yan2, Tetsuji Okamoto2 and Yoshiki Tokura1 1Department of Dermatology, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, and 2Department of Molecular Oral Medicine and Maxillofacial Surgery 1, Division of Frontier Medical Science, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan. E-mail: [email protected] Accepted May 7, 2008. Sir, at nucleotide position 667 within exon 3 and an intervening se- Naevoid basal cell carcinoma syndrome (NBCCS, OMIM quence (IVS)16 -3T > C, and a SNP; IVS10 -8T > C, were detected in all three cases. A deletion of AGAC causes a frameshift and a #109400), also called Gorlin’s syndrome, is an autosomal subsequent stop codon in exon 3, which prematurely truncates dominant disease that affects about 1 in 60,000 indivi- the protein (Fig. 1a). In addition, the IVS16 -3T > C could lead duals (1, 2). NBCCS is associated with various skeletal to an aberrant splicing and truncation of PTCH1 (10–12). and neurocutaneous abnormalities. Major manifestations To detect the expression level of PTCH1 protein in the skin, are multiple basal cell carcinomas (BCCs), odontogenic an immunohistochemical study was performed using goat poly- clonal anti-PTCH1 antibody (G-19; Santa Cruz Biotechnology, keratocysts, palmoplantar dyskeratotic pits and intra- Santa Cruz, CA, USA). Enzyme reactions were developed with cranial calcification (3). In addition, rib and vertebral conventional substrates for diamino-benzidine (Sigma, St Louis, malformations, epidermal cysts, macrocephaly, facial MO, USA) (13). -
Odontogenic Keratocyst with Ameloblastomatous Dentistry Section Transformation: a Rare Case Report
Case Report DOI: 10.7860/JCDR/2020/43336.13636 Odontogenic Keratocyst with Ameloblastomatous Dentistry Section Transformation: A Rare Case Report METEHAN KESKIN1, NILÜFER ÖZKAN2, NIHAT AKBULUT3, MEHMET CIHAN BEREKET4 ABSTRACT Odontogenic Keratocysts (OKC) are a developmental odontogenic cysts arising from remnants of the dental lamina. They differ from other odontogenic cysts due to their aggressive growth behaviour and high recurrence rates. Malignant or benign transformation may develop from their epithelium. Ameloblastomatous transformation of OKC is an extremely rare case. Such lesions have been described as combined or hybrid odontogenic lesions. In this case report, a 22-year-old patient presented with an unusual lesion in the mandible showing histological features of both OKC and ameloblastoma, and review of the available literature regarding the combined lesions. Keywords: Combined lesion, Hybrid lesion, Marginal resection, Mandible CASE REPORT corrugated parakeratosis, approximately 4-6 cell layers and palisaded A systemically healthy 22-year-old male patient was referred to basal cell layer resembling the OKC [Table/Fig-2a]. Some areas Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, inside the cyst wall showed stellate reticulum-like epithelial cells and Ondokuz Mayıs University, Turkey with painless swelling in the a basal cell layer of tall columnar cells with palisaded, revers polarised left lower jaw for 2 months. Three weeks before the first visit, the nuclei resembling the ameloblastomatous epithelium [Table/Fig-2b]. patient was prescribed antibiotics by another dental clinic because The lesion was diagnosed as Odontogenic Keratocyst (OKC) with of swelling in the left side of the jaw. On extraoral examination, a ameloblastomatous transformation. -
Challenges in Reporting Pathogenic/Potentially
www.nature.com/scientificreports OPEN Challenges in reporting pathogenic/ potentially pathogenic variants in 94 cancer predisposing genes - in pediatric patients screened with NGS panels Adela Chirita-Emandi 1,2,6*, Nicoleta Andreescu1,2,6, Cristian G. Zimbru1,3, Paul Tutac1,2, Smaranda Arghirescu4,5, Margit Serban5 & Maria Puiu1,2 The beneft of reporting unsolicited fndings in Next Generation Sequencing (NGS) related to cancer genes in children may have implications for family members, nevertheless, could also cause distress. We aimed to retrospectively investigate germline variants in 94 genes implicated in oncogenesis, in patients referred to NGS testing for various rare genetic diseases and reevaluate the utility of reporting diferent classes of pathogenicity. We used in silico prediction software to classify variants and conducted manual review to examine unsolicited fndings frequencies in 145 children with rare diseases, that underwent sequencing - using a 4813 gene panel. The anonymized reanalysis revealed 18250 variants, of which 126 were considered after fltering. Six pathogenic variants (in BRCA1,BMPR1A,FANCA,FANCC,NBN genes) with cancer related phenotype and three unsolicited variants (in BRCA2,PALB2,RAD50 genes) were reported to patients. Additionally, three unsolicited variants in ATR, BLM (in two individuals), and FANCB genes presented potential cancer susceptibility, were not reported to patients. In retrospect, 4.8% (7/145) of individuals in our cohort had unsolicited NGS fndings related to cancer. More eforts are needed to create an updatable consensus in reporting variants in cancer predisposing genes, especially for children. Consent process is crucial to inform of both value and risk of additional genetic information. Next-Generation Sequencing (NGS) for large panels of genes or exomes are increasingly and successfully used in medical management for rare diseases and cancer. -
Review of the Molecular Genetics of Basal Cell Carcinoma; Inherited Susceptibility, Somatic Mutations, and Targeted Therapeutics
cancers Review Review of the Molecular Genetics of Basal Cell Carcinoma; Inherited Susceptibility, Somatic Mutations, and Targeted Therapeutics James M. Kilgour , Justin L. Jia and Kavita Y. Sarin * Department of Dermatology, Stanford University School of Medcine, Stanford, CA 94305, USA; [email protected] (J.M.K.); [email protected] (J.L.J.) * Correspondence: [email protected] Simple Summary: Basal cell carcinoma is the most common human cancer worldwide. The molec- ular basis of BCC involves an interplay of inherited genetic susceptibility and somatic mutations, commonly induced by exposure to UV radiation. In this review, we outline the currently known germline and somatic mutations implicated in the pathogenesis of BCC with particular attention paid toward affected molecular pathways. We also discuss polymorphisms and associated phenotypic traits in addition to active areas of BCC research. We finally provide a brief overview of existing non-surgical treatments and emerging targeted therapeutics for BCC such as Hedgehog pathway inhibitors, immune modulators, and histone deacetylase inhibitors. Abstract: Basal cell carcinoma (BCC) is a significant public health concern, with more than 3 million cases occurring each year in the United States, and with an increasing incidence. The molecular basis of BCC is complex, involving an interplay of inherited genetic susceptibility, including single Citation: Kilgour, J.M.; Jia, J.L.; Sarin, nucleotide polymorphisms and genetic syndromes, and sporadic somatic mutations, often induced K.Y. Review of the Molecular Genetics of Basal Cell Carcinoma; by carcinogenic exposure to UV radiation. This review outlines the currently known germline and Inherited Susceptibility, Somatic somatic mutations implicated in the pathogenesis of BCC, including the key molecular pathways Mutations, and Targeted affected by these mutations, which drive oncogenesis. -
Cryotherapy in the Treatment of Glandular
Cryotherapy in the treatment of glandular odontogenic cyst: case report and review Crioterapia no tratamento de cisto odontogênico glandular: relato de caso e revisão Milene Borges Campagnaro* Raquel Medeiros Farias* Roger Correa de Barros Berthold** Márcia Rejane Brücker*** Fábio Dal Moro Maito**** Claiton Heitz***** Objective: The Glandular Odontogenic Cyst (GOC) is Introduction a rare benign odontogenic lesion, of considerable ag- gression, and often incorrectly diagnosed. We present a Glandular Odontogenic Cyst (GOC) was first patient with a Glandular Odontogenic Cyst in the pos- described by Gardner in 1988 as a distinct clinical terior mandible, its evolution, treatment, and follow-up. pathologic entity, and it was included in the WHO Case report: A female patient, 45 years old, was referred histological typing of odontogenic tumors under to the Oral and Maxillofacial Surgery and Traumatology GOC or sialo-odontogenic cyst1-5. Division at Cristo Redentor Hospital, Porto Alegre, Bra- Glandular Odontogenic Cyst is a rare lesion, of zil, for the assessment of a painful edema on the right considerable aggressive behavior, originated at the hemiface. A unilocular area with well-defined borders 1-5 in the retromolar region, posterior to the third molar on areas of dental support . Clinically, the most affec- the right side of the mandible. The histopathological ted site is the anterior part of the mandible and it examination suggested GOC. Final considerations: The mostly occurs in middle-aged patients with a slight Glandular Odontogenic Cyst needs a complete clinical male prevalence2,4-8. Epidemiological features are assessment associated with image analyses, and espe- scarce due to the rarity of the lesion and a review in cially, with histopathology for the correct diagnosis of 2008 pointed 111 cases published in the literature6. -
Glandular Odontogenic Cyst: Case Series and Summary of the Literature
502 > CLINICAL REVIEW http://dx.doi.org/10.17159/2519-0105/2019/v74no9a6 Glandular odontogenic cyst: case series and summary of the literature SADJ October 2019, Vol. 74 No. 9 p502 - p507 F Opondo1, S Shaik2, J Opperman3, CJ Nortjé4 ABSTRACT The glandular odontogenic cyst (GOC) remains a Histologically, it may mimic any one of a dentigerous rare entity. It was initially named “sialo-odontogenic cyst, radicular cyst, surgical ciliated cyst, lateral perio- cyst” by Padayachee and Van Wyk in 1987 when dontal cyst or a botryoid odontogenic cyst. Importantly, they reported the first two cases. Thereafter the the features of a cystic lesion with squamous and term glandular odontogenic cyst was suggested mucous epithelial elements may cause it to be mis- by Gardner et al. in 1988 and was subsequently diagnosed as a central mucoepidermoid carcinoma. adopted by the WHO.1 With more comprehensive diagnostic criteria, at least 180 In addition to its rarity, it has non-pathognomonic cases have so far been reported in the English literature.4 clinical and radiological features and hence can It is therefore reasonable to assume that the previous mimic other lesions. Since its recognition as an rarity of this entity may be attributable to misdiagnosis. entity by the WHO in 1992, only two further cases of glandular odontogenic cyst have been seen at CASE 1 the authors’ institution and are hereby reported together with a summary of the review articles in A 60-year-old man presented at the diagnostic clinic at the English literature. Tygerberg Oral Health Centre with an asymptomatic swelling of the anterior mandible.